Quadrileaflet stentless mitral valve replacement

Thoracic and Cardiovascular Surgeon

Volumn 47, Issue 6, 1999, Pages 357-360

  Walther, Thomas ^a   Walther, C ^a   Falk, V ^a   Langebartels, G ^a   Kruger M ^a   Dagge, A ^a   Diegeler, A ^a   Autschbach, R ^a   Mohr, F W ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Echocardiography; Mitral valve surgery; Stentless bioprostheses

Indexed keywords

AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEART INDEX; HEART LEFT VENTRICLE FUNCTION; HEART VALVE PROSTHESIS; HEART VENTRICLE PRESSURE; HEMODYNAMIC PARAMETERS; HUMAN; MALE; MITRAL VALVE REPLACEMENT; PRIORITY JOURNAL; SINUS RHYTHM; TREATMENT OUTCOME;

EID: 0033389603     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1013174     Document Type: Article

References (15)

1. Collins JJ. The evolution of artificial heart valves. Editorial. N Engl J Med. 1991;324 : 624-6.
2. Wernly JA, Crawford MH. Choosing a prosthetic heart valve. Cardiology Clinics. 1991;9 : 329-38.
3. Murakami T, Eishi K, Nakano S, et al. Aortic and mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 10-year results. J Heart Valve Dis. 1996;5 : 45-9.
4. Bernal JM, Rabasa JM, Lopez R, Nistal JF, Muniz R, Revuelta JM. Durability of the Carpentier-Edwards porcine bioprosthesis: role of age and valve position. Ann Thorac Surg. 1995;60 (Suppl 2) : S248-52.
5. Fann JI, Miller DC, Moore KA, et al. Twenty-year clinical experience with porcine bioprostheses. Ann Thorac Surg. 1996;62 : 1301-12.
6. Cohn LH, Allred EN, DiSesa VJ, Sawtelle K, Shemin RJ, Collins JJ. Early and late risk of aortic valve replacement. J Thorac Cardiovasc Surg. 1984;88 : 695-705.
7. Edmunds LH. Thrombotic and bleeding complications of prosthetic heart valves. Ann Thorac Surg. 1987;44 : 430-45.
8. Jamieson WR. Modern cardiac valve devices - bioprostheses and mechanical prostheses: State of the art. J Card Surg. 1993;8 : 89-98.
9. Rankin SL, Briffa TG, Morton AR, Hung J. A specific activity questionnaire to measure the functional capacity of cardiac patients. Am J Cardiol. 1996;77 : 1220-3.
10. Johnson DM, Sapirstein W. FDA's requirements for in-vivo performance data for prosthetic heart valves. J Heart Valve Dis. 1994;3 : 350-5.
11. Mohr FW, Falk V, Diegeler A, Walther T, van Son JAM, Autschbach R. Minimally invasive port-access mitral valve surgery. J Thorac Cardiovasc Surg. 1998;115 : 567-76.
12. Edmunds LH, Clark RE, Cohn LH, Grunkemeier GL, Miller C, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg. 1996;62 : 932-5.
13. Frater RWM, Liao K, Seifter E. Stentless chordally supported mitral bioprosthetic valve. New horizons and the future of heart valve bioprostheses, 1 ed. 1994 : 103-19.
14. Hetzer R, Bougioukas G, Franz M, Borst HG. Mitral valve replacement with preservation of papillary muscles and chordae tendineae - revival of a seemingly forgotten concept. Thorac Cardiovasc Surg. 1983;31 : 291-6.
15. David TE, Uden DE, Strauss HD. The importance of the mitral apparatus in left ventricular function after correction of mitral regurgitation. Circulation. 1986;74 : 116-20.